These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

T. Rowe Price carries a Zacks Rank #3 and a +2.93% Earnings ESP ahead of its October 30, 2026 results, with the most accurate EPS estimate at $2.69 versus $2.61 consensus. Ares Management also has a Rank #3 and a +0.47% ESP, with a $1.33 estimate versus $1.32 consensus ahead of November 2 earnings. The positive ESP readings indicate a modestly improved probability that both asset managers will exceed quarterly earnings expectations, though neither has yet reported results.

Analysis

This is not an investable signal by itself: both indicated estimate gaps are small relative to normal earnings-estimate noise, and the source has an embedded incentive to promote a proprietary screening methodology. The more relevant question is whether each company can raise forward earnings power through net flows, fee rates, and realization/deployment activity—not whether it clears a quarterly EPS bar. A beat without improved forward guidance is likely to be sold, particularly if recent relative performance has lifted expectations.

TROW's asymmetry is tied to market-sensitive AUM and organic flows. A quarter aided by equity-market appreciation or expense discipline does little to resolve the structural risk from persistent active-management outflows and fee compression; a durable rerating requires credible positive long-term net flows, especially in retirement, fixed income, or ETF products. Near term, falling rates and stronger risk assets can support AUM-related revenue over the next 1-3 months, but the 6-18 month outcome depends on whether distribution costs rise faster than revenue.

ARES has the cleaner structural setup, but also a more valuation-sensitive one: fundraising, fee-related earnings, and deployment into private credit can compound over 6-18 months if capital markets remain open. The underappreciated risk is that credit stress creates a lagged mismatch—deployment and marks may initially support reported economics while later non-accruals, lower realizations, and slower fundraising pressure performance fees. A modest EPS beat is therefore less important than management commentary on fundraising velocity, insurance capital, deployment yields, and underlying portfolio losses.

Contrarian view: the market routinely treats alternative-asset managers as rate beneficiaries, but abrupt rate declines can simultaneously help marks and reduce private-credit asset yields. That makes ARES's spread and credit-quality disclosures more important than directional rate moves. For TROW, an earnings trade is unattractive unless flow data demonstrate an inflection; a mechanical beat could create a better short-entry opportunity if guidance remains unchanged.

Key Decisions for Investors

• No standalone pre-earnings position based on the estimate-screen signal; require current implied move, short interest, and post-results revision history before deploying event risk.
• Prefer a 6-12 month long ARES / short TROW pair, sized beta-neutral, if ARES confirms fundraising growth and stable credit losses while TROW reports continued net outflows. The trade expresses private-capital fee durability versus public active-management fee pressure; exit if ARES reports material non-accrual deterioration or TROW delivers two consecutive quarters of organic inflow improvement.
• For ARES earnings, use a defined-risk call spread only if implied volatility prices less than the stock's historical post-earnings move and management provides evidence of accelerating fee-paying AUM. Upside catalyst is forward fee-related earnings guidance, not a small EPS beat; downside is credit-mark or fundraising disappointment.
• Monitor TROW's organic net flows, fee rate, operating-margin guidance, and retirement-platform retention at results. Consider a tactical short only after a beat-and-fade setup where EPS exceeds expectations but management does not improve flow or revenue guidance; cover on verified flow stabilization.
• Monitor ARES portfolio non-accruals, realized-loss commentary, deployment pace, and fundraising backlog over the next two quarters. A widening private-credit stress signal or weaker-than-expected insurance-channel inflows falsifies the long leg before reported earnings do.